Vanguard Group Inc Cor Medix Inc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Cor Medix Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,378,191 shares of CRMD stock, worth $35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,378,191

Previous 3,068,677 10.09%

Holding current value

$35 Million

Previous $24.8 Million 10.36%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$8.1 - $13.59 $2.51 Million - $4.21 Million	309,514 Added 10.09%	3,378,191 $27.4 Million
Q3 2024 Nov 13, 2024	BUY	$3.64 - $8.23 $604,775 - $1.37 Million	166,147 Added 5.72%	3,068,677 $24.8 Million
Q2 2024 Aug 13, 2024	SELL	$4.08 - $6.39 $104,676 - $163,941	-25,656 Reduced 0.88%	2,902,530 $12.6 Million
Q1 2024 May 10, 2024	BUY	$2.94 - $4.24 $302,381 - $436,088	102,851 Added 3.64%	2,928,186 $12.4 Million
Q4 2023 Feb 14, 2024	BUY	$3.0 - $4.01 $523,761 - $700,093	174,587 Added 6.59%	2,825,335 $10.6 Million
Q3 2023 Nov 14, 2023	BUY	$3.6 - $4.46 $350,823 - $434,631	97,451 Added 3.82%	2,650,748 $9.81 Million
Q2 2023 Aug 14, 2023	BUY	$3.94 - $5.8 $2.43 Million - $3.57 Million	615,536 Added 31.77%	2,553,297 $10.1 Million
Q1 2023 May 15, 2023	BUY	$3.22 - $4.61 $452,200 - $647,405	140,435 Added 7.81%	1,937,761 $8.02 Million
Q4 2022 Feb 10, 2023	BUY	$2.81 - $4.45 $2,304 - $3,649	820 Added 0.05%	1,797,326 $7.58 Million
Q3 2022 Nov 14, 2022	BUY	$2.82 - $7.52 $399,030 - $1.06 Million	141,500 Added 8.55%	1,796,506 $5.08 Million
Q2 2022 Aug 12, 2022	SELL	$2.73 - $5.61 $434,804 - $893,499	-159,269 Reduced 8.78%	1,655,006 $6.65 Million
Q1 2022 May 13, 2022	SELL	$3.83 - $6.24 $25,756 - $41,964	-6,725 Reduced 0.37%	1,814,275 $9.94 Million
Q4 2021 Feb 14, 2022	BUY	$4.47 - $5.56 $44,941 - $55,900	10,054 Added 0.56%	1,821,000 $8.29 Million
Q3 2021 Nov 12, 2021	BUY	$4.46 - $7.11 $315,857 - $503,530	70,820 Added 4.07%	1,810,946 $8.42 Million
Q2 2021 Aug 13, 2021	BUY	$6.05 - $10.09 $10.5 Million - $17.6 Million	1,740,126 New	1,740,126 $11.9 Million

Others Institutions Holding CRMD

# of Institutions

135

Shares Held

21.9M

Call Options Held

599K

Put Options Held

401K

View Full List

About CorMedix Inc.

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $427M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

More about CRMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Cor Medix Inc. Transaction History